Artificial Intelligence

A new AI trading bot promises hands-free profits, but a lack of regulatory oversight and performance data raises critical questions for new investors.

A new tokenized offering bundles 100 IP-based companies, pioneering an industrialized approach to innovation finance amid growing regulatory clarity.

With a $50M state investment and a new White House directive, Texas is pioneering ibogaine research. But can it overcome the drug's risks and legal hurdles?

Adobe's Frame.io leverages Suite Studios' streaming tech to make cloud files act like local drives, aiming to eliminate downloads and revolutionize remote work.

The amended $12M deal introduces a milestone-linked warrant and sets the stage for AIxCrypto to tokenize Faraday Future's stock, bridging EVs and Web3.

New preclinical data shows SK Life Science Labs' protein degraders effectively target key drivers in prostate cancer, myeloma, and other hard-to-treat tumors.

A $2.5M gift honors a legacy and empowers a top scientist to develop imaging tech that could revolutionize how we diagnose and treat blindness.

New data reveals a novel cancer drug shrinks brain metastases in over half of small cell lung cancer patients, offering hope where options are scarce.

With $10M in new funding, Creao AI is building a 'closed-loop' system where AI builds and runs its own tools, promising one person the power of a team.

A new AI platform claims to find, analyze, and negotiate property deals with minimal human input, blurring the line between support tool and transaction agent.

Hainan's 2026 consumer expo showcases flying cars and global brands, all powered by its new, ambitious free trade port policies that are reshaping trade.

Genomic Prediction reappoints its founding CEO, Laurent Tellier, signaling a push for innovation amid ethical debates and questions about its market standing.

Presented at AACR 2026, first-in-class antibody IMT-009 shows clinical benefit in tough cancers, potentially paving the way for a new precision therapy.

New data on ATX-295 reveals a potent attack on unstable tumors, guided by an AI biomarker that could change how we select patients for treatment.

Dynamite Wallet wants to make your face your private key. This leap in usability could ignite mass adoption, but it also raises critical security questions.

Interim study results suggest a common food product may significantly enhance the effectiveness of modern cancer treatments, heralding a new era of care.

A surprise $5 million pledge for glaucoma research highlights a gala honoring philanthropist Daria Barry, patient advocate Hillary Golden, and music icon Nile Rodgers.

The $4.1 trillion U.S. Latino economy is being leveraged to tackle energy costs, infrastructure challenges, and the soaring demands of AI technology.

For the first time, a major regulatory body has approved a drug name created by AI, signaling a new era for the highly regulated pharmaceutical industry.

The era of monolithic chips is ending. A new wave of system-level design using advanced packaging is solving AI's biggest power and bandwidth challenges.